65 related articles for article (PubMed ID: 14985112)
1. A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2.
Wu X; Zhao R; Li Z; Yao M; Wang H; Han J; Qu S; Chen X; Qian L; Sun Y; Xu Y; Gu J
Biochem Biophys Res Commun; 2004 Mar; 315(4):1004-10. PubMed ID: 14985112
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.
Barton WA; Tzvetkova-Robev D; Miranda EP; Kolev MV; Rajashankar KR; Himanen JP; Nikolov DB
Nat Struct Mol Biol; 2006 Jun; 13(6):524-32. PubMed ID: 16732286
[TBL] [Abstract][Full Text] [Related]
3. Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization.
Bogdanovic E; Nguyen VP; Dumont DJ
J Cell Sci; 2006 Sep; 119(Pt 17):3551-60. PubMed ID: 16895971
[TBL] [Abstract][Full Text] [Related]
4. A novel gene delivery system targeting Tie2 for cancer gene therapy.
Hu A; Wu X; Li Z; Wang H; Li J; Yao M; Chen X; Qu S; Xu Y; Gu J
Anticancer Res; 2010 Jun; 30(6):1999-2004. PubMed ID: 20651343
[TBL] [Abstract][Full Text] [Related]
5. Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition.
Barton WA; Tzvetkova D; Nikolov DB
Structure; 2005 May; 13(5):825-32. PubMed ID: 15893672
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering.
Davis S; Papadopoulos N; Aldrich TH; Maisonpierre PC; Huang T; Kovac L; Xu A; Leidich R; Radziejewska E; Rafique A; Goldberg J; Jain V; Bailey K; Karow M; Fandl J; Samuelsson SJ; Ioffe E; Rudge JS; Daly TJ; Radziejewski C; Yancopoulos GD
Nat Struct Biol; 2003 Jan; 10(1):38-44. PubMed ID: 12469114
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM
J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy.
Wu X; Li Z; Yao M; Wang H; Qu S; Chen X; Li J; Sun Y; Xu Y; Gu J
Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):217-25. PubMed ID: 18330476
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
[TBL] [Abstract][Full Text] [Related]
11. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
[TBL] [Abstract][Full Text] [Related]
12. Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
DeNardo SJ; Yao Z; Lam KS; Song A; Burke PA; Mirick GR; Lamborn KR; O'Donnell RT; DeNardo GL
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3854S-64S. PubMed ID: 14506183
[TBL] [Abstract][Full Text] [Related]
13. Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis.
Milner CS; Hansen TM; Singh H; Brindle NP
Microvasc Res; 2009 Mar; 77(2):187-91. PubMed ID: 18848573
[TBL] [Abstract][Full Text] [Related]
14. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
[TBL] [Abstract][Full Text] [Related]
16. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
17. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat.
Sandhu R; Teichert-Kuliszewska K; Nag S; Proteau G; Robb MJ; Campbell AI; Kuliszewski MA; Kutryk MJ; Stewart DJ
Cardiovasc Res; 2004 Oct; 64(1):115-24. PubMed ID: 15364619
[TBL] [Abstract][Full Text] [Related]
19. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
Shlamkovich T; Aharon L; Barton WA; Papo N
Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
[TBL] [Abstract][Full Text] [Related]
20. Design of a novel small peptide targeted against a tumor-specific receptor.
Campa MJ; Kuan CT; O'Connor-McCourt MD; Bigner DD; Patz EF
Biochem Biophys Res Commun; 2000 Aug; 275(2):631-6. PubMed ID: 10964715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
